GeneDx to acquire Fabric Genomics for $33M in cash at closing

GeneDx (WGS) announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation. The transaction enables GeneDx’s leadership in the next phase of genomic medicine: decentralized testing with centralized intelligence. Under the terms of the agreement, and subject to the terms and conditions thereof, GeneDx will pay up to an aggregate of $33M in cash upon closing with total consideration potentially up to an aggregate of $51M upon achievement of certain milestones. The acquisition, which has been approved unanimously by the company’s Board of Directors, is expected to close in the second quarter of 2025, subject to closing conditions.